Dementia and Alzheimer's are not the same thing, but Alzheimer's is a type of dementia

Dementia is an umbrella term for a group of symptoms—memory loss, difficulty with language, problems with reasoning—that result from damage to brain cells. Alzheimer's disease is one specific cause of those symptoms. Think of dementia as the symptom pattern and Alzheimer's as one of several diseases that produce it.

When doctors say someone "has dementia," they are describing what is happening. When they say someone "has Alzheimer's disease," they are identifying why it is happening. A person with Alzheimer's will develop dementia symptoms, but not everyone with dementia symptoms has Alzheimer's. Other diseases—vascular dementia from small strokes, Lewy body dementia from protein deposits, frontotemporal dementia from nerve cell loss in the front and sides of the brain—produce the same outward symptoms but work differently inside the brain.

Key Takeaways

  • Alzheimer's disease is one specific cause of dementia symptoms, not a progression from a general dementia diagnosis.
  • A doctor determines whether someone has Alzheimer's or another type of dementia through cognitive testing, brain imaging, and sometimes spinal fluid analysis or PET scans.
  • Alzheimer's accounts for 60 to 80 percent of dementia cases, making it the most common cause, but other diseases produce similar symptoms.
  • The type of dementia matters because different causes respond to different treatments and progress at different rates.
  • Some people have mixed dementia—damage from Alzheimer's and vascular disease, or Alzheimer's and Lewy body disease—which complicates both diagnosis and treatment.

How doctors tell the difference between types of dementia

A diagnosis of "dementia" alone is incomplete. A doctor needs to identify which disease is causing the symptoms because treatment and prognosis depend on the underlying cause. The process starts with a detailed history: when symptoms began, how they have changed, what the person can and cannot do now. The doctor will ask about falls, hallucinations, mood changes, and sleep problems—each points toward a different disease.

Cognitive testing comes next. The Mini-Cog, Montreal Cognitive Assessment, or similar tools measure memory, attention, language, and reasoning. These tests show what is broken but not why. Brain imaging—usually an MRI or CT scan—reveals whether the brain has shrunk in patterns typical of Alzheimer's, or whether there are signs of small strokes (vascular dementia), or whether the damage is concentrated in the front of the brain (frontotemporal dementia).

For Alzheimer's specifically, newer tests can detect the actual proteins involved. A PET scan can show amyloid and tau deposits in the brain. A spinal tap can measure amyloid and tau in cerebrospinal fluid. Blood tests for phosphorylated tau and amyloid are becoming more widely available. These tests do not change the diagnosis for most people—the clinical picture usually makes it clear—but they can confirm Alzheimer's when the symptoms are ambiguous or when the person is still in early stages.

Why Alzheimer's is the most common type of dementia

Alzheimer's disease accounts for 60 to 80 percent of dementia cases. The disease involves two main problems: amyloid plaques that build up between brain cells and tau tangles that form inside them. Over years or decades, these accumulate and kill neurons, particularly in the hippocampus and cortex—regions critical for memory and thinking.

The disease usually begins silently. Brain changes can start 10 to 20 years before any symptoms appear. By the time someone notices memory problems, significant damage has already occurred. This is why Alzheimer's is so common in dementia diagnoses: it is a slow disease that affects many people long enough to produce noticeable symptoms.

Age is the strongest risk factor. Alzheimer's is rare before age 60 but becomes more common with each decade after 65. Family history matters—having a parent or sibling with Alzheimer's increases risk, particularly if they developed it before age 65. Genetics play a role; the APOE4 gene variant increases risk substantially. But genetics are not destiny. Many people with APOE4 never develop Alzheimer's, and many without it do.

Mixed dementia: when more than one disease is present

Many people have damage from more than one disease at the same time. The most common combination is Alzheimer's plus vascular dementia—amyloid and tau plaques plus damage from small strokes. Someone might also have Lewy body disease (the protein alpha-synuclein) alongside Alzheimer's changes. Autopsy studies show that mixed dementia is present in roughly one-third of people who had dementia symptoms during life.

Mixed dementia complicates diagnosis because the symptoms overlap and the imaging may show signs of multiple diseases. It also affects how the disease progresses. Someone with Alzheimer's alone may decline gradually over 8 to 12 years. Someone with Alzheimer's plus vascular disease may have a stepwise pattern—stable for months, then a sudden decline after a small stroke, then stable again. Treatment becomes more complex because medications for Alzheimer's may help, but managing blood pressure and stroke risk also becomes critical.

What happens after a dementia diagnosis

Once a doctor has identified the type of dementia, the next step is understanding what treatments are available and what to expect. For Alzheimer's disease, medications like donepezil, rivastigmine, and galantamine can slow cognitive decline in early and middle stages for some people—typically delaying worsening by several months. Aducanumab and lecanemab are newer drugs that target amyloid directly, though they carry risks and are used in specific circumstances.

For other types of dementia, the treatment approach differs. Vascular dementia is managed partly through stroke prevention—blood pressure control, antiplatelet drugs, managing diabetes. Lewy body dementia responds poorly to standard Alzheimer's drugs but may respond to different medications. Frontotemporal dementia has no disease-modifying treatment yet, though research is ongoing.

Beyond medication, the diagnosis guides planning. Knowing the type of dementia helps predict how symptoms will change, which allows families to arrange care, modify the home, and make decisions about driving, finances, and advance directives while the person can still participate. It also connects people to research studies and clinical trials specific to their disease.

The difference between having Alzheimer's risk and having Alzheimer's disease

Genetic testing and biomarker tests have created a new category: people who have Alzheimer's pathology in their brain but no symptoms yet. Someone might have a PET scan or blood test showing amyloid and tau, or they might carry the APOE4 gene, but still have normal memory and thinking. This is sometimes called "preclinical Alzheimer's" or "asymptomatic Alzheimer's disease."

This distinction matters because it separates risk from disease. Having amyloid in your brain does not mean you will develop symptoms in your lifetime. Many older adults have autopsy-confirmed Alzheimer's pathology but died of something else before symptoms appeared. Genetic risk is real but not certain. The presence of biomarkers means the disease process has begun, but it does not predict when or whether symptoms will emerge.

Research is exploring whether treating people at this stage—before symptoms appear—can prevent or delay dementia. Some trials are testing whether medications, cognitive training, or lifestyle changes can slow the accumulation of amyloid and tau. These studies are ongoing, and no treatment is currently recommended for asymptomatic people outside of research settings.

What you should know about dementia screening and testing

If you or someone you know has noticed memory problems or changes in thinking, the first step is a visit to a primary care doctor. The doctor will take a history, do basic cognitive screening, and may refer to a neurologist or geriatrician for more detailed testing. This process is not fast—a complete workup can take several weeks—but rushing does not improve accuracy.

Imaging and blood tests are tools, not diagnoses. A normal MRI does not rule out Alzheimer's; early Alzheimer's may not show obvious shrinkage. An abnormal amyloid blood test does not mean someone has dementia; it means the disease process is present. The diagnosis comes from combining the clinical picture—what the person can and cannot do, how symptoms have changed—with test results.

If you receive a dementia diagnosis, ask specifically which type. "Dementia" alone is incomplete information. Ask what treatments are available for that specific type, what the expected progression is, and whether the doctor recommends any imaging or biomarker testing. Ask about clinical trials. Ask what to watch for and when to return for follow-up.

Frequently Asked Questions

If I have early dementia, will it definitely turn into Alzheimer's?

No. Early dementia symptoms could be from Alzheimer's, vascular disease, Lewy body disease, or another cause. Only testing and clinical evaluation can determine which disease is present. The type matters because it affects treatment options and how the disease will progress.

Can you have Alzheimer's without having dementia?

Yes. Alzheimer's pathology—amyloid and tau—can be present in the brain for years before symptoms appear. Some people die with Alzheimer's changes in their brain but never developed noticeable memory or thinking problems during life. This is why researchers distinguish between the disease process and the symptoms it causes.

Does a family history of Alzheimer's mean I will definitely get it?

No. Family history increases risk, especially if a parent developed Alzheimer's before age 65, but it does not may provide you will develop it. Many people with a strong family history never develop dementia. Genetics are one factor among many, including age, education, cardiovascular health, and cognitive activity.

How long does it take to get a dementia diagnosis?

The process typically takes several weeks to a few months. Your doctor will need time to take a detailed history, perform cognitive testing, and arrange imaging or other tests. Rushing does not improve accuracy. If you are concerned about symptoms, starting with your primary care doctor is the fastest path to evaluation.

Are there treatments that can stop Alzheimer's disease?

No current treatment stops Alzheimer's. Some medications can slow cognitive decline in early and middle stages for some people, typically delaying worsening by several months. Newer drugs targeting amyloid show promise but work best in early stages and carry risks. Research into prevention and earlier treatment is ongoing.